Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Ford

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Lancet. Respiratory Medicine|May 25, 2018
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trialToby M Maher, Ellen M van der Aar, Olivier Van de Steen, et al.
Plos One|June 2, 2016
Peritoneal Dialysate Glucose Load and Systemic Glucose Metabolism in Non-Diabetics: Results from the GLOBAL Fluid Cohort StudyMark Lambie, James Chess, Jun-Young Do, et al.
Medical Mycology|June 27, 2024
Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens listMrudhula Asogan, Hannah Yejin Kim, Sarah Kidd, et al.
Advances in Therapy|October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial DesignEva Santermans, Paul Ford, Michael Kreuter, et al.
Medical Mycology|June 27, 2024
Histoplasmosis: A systematic review to inform the World Health Organization of a fungal priority pathogens listAiken Dao, Hannah Yejin Kim, Catriona L Halliday, et al.
ERJ Open Research|January 30, 2024
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosisPaul Ford, Michael Kreuter, Kevin K Brown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2023
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Christopher P Denton, Daniel E Furst, et al.
Journal of Neural Engineering|March 19, 2026
Solving the problem of inception: A cross-species perspective on strategies for a mechanistic refinement of intracortical microstimulationTakashi D Yoshida Kozai, Bryan Mac Hooks, Alberto L Vazquez, et al.
ERJ Open Research|February 18, 2026
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trialsMatthew J Randall, Claus A Andersen, Kevin K Brown, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 6, 2018
Comparison of <sup>3</sup> He and <sup>129</sup> Xe MRI for evaluation of lung microstructure and ventilation at 1.5TNeil J Stewart, Ho-Fung Chan, Paul J C Hughes, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Lancet. Respiratory Medicine|May 25, 2018
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trialToby M Maher, Ellen M van der Aar, Olivier Van de Steen, et al.
Plos One|June 2, 2016
Peritoneal Dialysate Glucose Load and Systemic Glucose Metabolism in Non-Diabetics: Results from the GLOBAL Fluid Cohort StudyMark Lambie, James Chess, Jun-Young Do, et al.
Medical Mycology|June 27, 2024
Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens listMrudhula Asogan, Hannah Yejin Kim, Sarah Kidd, et al.
Advances in Therapy|October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial DesignEva Santermans, Paul Ford, Michael Kreuter, et al.
Medical Mycology|June 27, 2024
Histoplasmosis: A systematic review to inform the World Health Organization of a fungal priority pathogens listAiken Dao, Hannah Yejin Kim, Catriona L Halliday, et al.
ERJ Open Research|January 30, 2024
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosisPaul Ford, Michael Kreuter, Kevin K Brown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2023
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Christopher P Denton, Daniel E Furst, et al.
Journal of Neural Engineering|March 19, 2026
Solving the problem of inception: A cross-species perspective on strategies for a mechanistic refinement of intracortical microstimulationTakashi D Yoshida Kozai, Bryan Mac Hooks, Alberto L Vazquez, et al.
ERJ Open Research|February 18, 2026
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trialsMatthew J Randall, Claus A Andersen, Kevin K Brown, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 6, 2018
Comparison of <sup>3</sup> He and <sup>129</sup> Xe MRI for evaluation of lung microstructure and ventilation at 1.5TNeil J Stewart, Ho-Fung Chan, Paul J C Hughes, et al.
Pageof 5